Fidelity Investments’s Pelagos Insurance Capital PLGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Buy
5,991
+640
+12% +$13.9K ﹤0.01% 3807
2026
Q1
$102K Buy
5,351
+2,796
+109% +$53.5K ﹤0.01% 3786
2025
Q4
$50K Buy
2,555
+19
+0.7% +$354 ﹤0.01% 4117
2025
Q3
$46K Buy
2,536
+93
+4% +$1.55K ﹤0.01% 4009
2025
Q2
$40.5K Sell
2,443
-21,173
-90% -$351K ﹤0.01% 3991
2025
Q1
$383K Sell
23,616
-1,284,686
-98% -$20.5M ﹤0.01% 2995
2024
Q4
$23.7M Buy
1,308,302
+8,722
+0.7% +$162K ﹤0.01% 1663
2024
Q3
$23.5M Buy
1,299,580
+207
+0% +$3.65K ﹤0.01% 1655
2024
Q2
$21.2M Buy
1,299,373
+471,246
+57% +$8.35M ﹤0.01% 1628
2024
Q1
$16.1M Buy
828,127
+828,082
+1,840,182% +$12.2M ﹤0.01% 1728
2023
Q4
$570 Buy
45
+42
+1,400% +$564 ﹤0.01% 4807
2023
Q3
$44 Buy
+3
New +$42 ﹤0.01% 4954

Other funds holding PLGO

Fidelity Investments's PLGO Position: Q2 2026 in Review

Fidelity Investments increased its Pelagos Insurance Capital (PLGO) stake by 12% in Q2 2026, buying an estimated $13.9K and bringing the position to 5,991 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #3807.

Fidelity Investments first reported a position in PLGO in Q3 2023 and has held it in 12 quarters since. The position peaked at $23.7M in Q4 2024. 189 funds tracked by Wall St. Rank hold PLGO as of Q2 2026.

  • Fidelity Investments held 5,991 shares of Pelagos Insurance Capital worth $146K as of Q2 2026.
  • Fidelity Investments bought 640 Pelagos Insurance Capital shares in Q2 2026, an estimated $13.9K.
  • Pelagos Insurance Capital made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3807 holding.
  • Fidelity Investments first reported a position in Pelagos Insurance Capital in Q3 2023 and has held it in 12 quarters since.
  • Fidelity Investments's Pelagos Insurance Capital position peaked at $23.7M in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Pelagos Insurance Capital as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.